Andrew Reardon
General Counsel at LIGAND PHARMACEUTICALS INCORPORATED
Net worth: 2 M $ as of 29/04/2024
Network origin in Andrew Reardon first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 19 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Andrew Reardon via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| OMNIAB, INC. | Miscellaneous Commercial Services | Chief Executive Officer General Counsel Director/Board Member Chairman Chief Tech/Sci/R&D Officer | |
OmniAb Operations, Inc.
 OmniAb Operations, Inc. BiotechnologyHealth Technology OmniAb Operations, Inc. operates as a drug discovery company. It provides pharmaceutical industry partners access to antibody repertoires and screening technologies to enable discovery of next-generation therapeutics. Its OmniAb platform includes the Biological Intelligence of its transgenic animals, including OmniRat, OmniChicken and OmniMouse, that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company is headquartered in Emeryville, CA. | Biotechnology | Chief Executive Officer General Counsel Director/Board Member Chairman | |
| PFENEX INC. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
| Colgate University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Ligand UK Research Ltd.
 Ligand UK Research Ltd. Pharmaceuticals: MajorHealth Technology Part of Ligand Pharmaceuticals, Inc., Ligand UK Research Ltd. develops pharmaceutical products. The company is based in London, UK. Founded in 1995. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
Ligand UK Group Ltd.
 Ligand UK Group Ltd. Financial ConglomeratesFinance Founded in 1995, Ligand UK Group Ltd. is a subsidiary of Ligand Pharmaceuticals, Inc. and functions as an investment holding company. The company is based in Cambridge, UK. | Financial Conglomerates | Director/Board Member Director/Board Member Director/Board Member | |
| VERNALIS | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| The University of Texas at Austin | College/University | Corporate Officer/Principal Undergraduate Degree | |
| Yale University | College/University | Undergraduate Degree Undergraduate Degree | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Metabasis Therapeutics, Inc.
 Metabasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Metabasis Therapeutics, Inc. engages in discovery, development and commercialization of novel drugs for metabolic diseases using the proprietary technology and the knowledge of processes and pathways within the liver that are useful for liver-selective drug targeting and treatment of metabolic diseases. Metabasis was incorporated in April 1997 and is headquartered in La Jolla, CA. | Pharmaceuticals: Major | Corporate Secretary Chief Executive Officer | |
| ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel | |
| Gordon Research Conferences | Director/Board Member Chief Executive Officer | ||
| Boston College | College/University | Undergraduate Degree Director/Board Member | |
Nuron Biotech, Inc.
 Nuron Biotech, Inc. BiotechnologyHealth Technology Nuron Biotech, Inc. markets and develops vaccines for the prevention and treatment of infectious diseases. It develops novel biologics and vaccines for the prevention and treatment of neurodegenerative and infectious diseases. The firm is advancing products to meet unmet medical needs in the areas of multiple sclerosis, alzheimer's, hepatitis b and hepatitis c for patients across the globe. The company was founded by Vithalbhai Dhaduk, Shankar Musunuri and David Zeng in 2009 and is headquartered in Exton, PA. | Biotechnology | Director/Board Member | |
| Harvard Business School | College/University | Masters Business Admin | |
| OLD API WIND-DOWN LTD. | Pharmaceuticals: Major | Director/Board Member | |
Benuvia Therapeutics, Inc.
 Benuvia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Benuvia Therapeutics, Inc. engages in pharmaceutical and therapeutic drug development services. The company is headquartered in Chandler, AZ. | Pharmaceuticals: Major | Chief Executive Officer | |
| VAXART, INC. | Biotechnology | Chairman | |
Palvella Therapeutics, Inc.
 Palvella Therapeutics, Inc. BiotechnologyHealth Technology Palvella Therapeutics, Inc. operates as a rare disease biopharmaceutical company. It develops and commercializes pathogenetically targeted therapies for rare genodermatoses with no approved treatments. Its products include QTORIN, PTX-022, PTX-367, and PTX-014. The company was founded by Wesley H. Kaupinen in 2015 and is headquartered in Wayne, PA. | Biotechnology | Director/Board Member | |
Royaltyrx Capital LLC
 Royaltyrx Capital LLC Financial ConglomeratesFinance Royaltyrx Capital LLC provides investment services in the pharmaceutical industry. The American company was founded by Todd C. Davis. | Financial Conglomerates | Founder | |
| Harvard Business School Health Industry Alumni Association | Director/Board Member | ||
| BIODELIVERY SCIENCES INTERNATIONAL, INC. | Pharmaceuticals: Major | Director/Board Member | |
AcuFocus, Inc.
 AcuFocus, Inc. Medical SpecialtiesHealth Technology AcuFocus, Inc. develops KAMRA inlay for the treatment of presbyopia. Its KAMRA inlay is an intra-corneal inlay designed to create a small aperture effect, allowing the eye to see near and intermediate objects more clearly. The company was founded in 2001 and is headquartered in Irvine, CA. | Medical Specialties | Director/Board Member | |
| IMMUNOMEDICS, INC. | Biotechnology | Director/Board Member | |
Helomics Corp.
 Helomics Corp. Medical/Nursing ServicesHealth Services Helomics Corp. provides cancer care development and treatment consulting services. Its products include chemoFx, biospeciFx, geneFx colon and geneFx lung. It also offers research and development services. The company was founded in 1995 and is headquartered in Pittsburgh, PA. | Medical/Nursing Services | Chairman | |
| ANEBULO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Orchestra BioMed, Inc.
 Orchestra BioMed, Inc. Medical SpecialtiesHealth Technology Orchestra BioMed, Inc. develops therapies for cardiovascular diseases. The firm offers BackBeat CNT and Virtue SEB. The company was founded in 2017 and is headquartered in New Hope, PA. | Medical Specialties | Director/Board Member | |
| United States Naval Academy | College/University | Undergraduate Degree | |
Cytovia Therapeutics, Inc.
 Cytovia Therapeutics, Inc. BiotechnologyHealth Technology Cytovia Therapeutics, Inc. engages in transformational immunotherapies for cancer and severe acute infectious diseases. Its products include Multi-Specific NK Engager Antibodies and iPSC CAR NK cells. The company was founded by Daniel Teper, Gilles Seydoux, and Massimo Radaelli and is headquartered in New York, NY. | Biotechnology | Director/Board Member | |
| Rio Grande Renewables LLC | Founder | ||
| ORCHESTRA BIOMED HOLDINGS, INC. | Medical Specialties | Director/Board Member | |
Elan Pharmaceuticals, LLC
 Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal | |
Virocell Biologics Ltd.
 Virocell Biologics Ltd. BiotechnologyHealth Technology Virocell Biologics Ltd. is an innovation-driven Contract Development and Manufacturing Organization (CDMO) that manufactures viral vectors and gene-modified cells to enable novel cell and gene therapies to enter clinical trials. The company is based in London, UK. The British company leverages its expertise in vector manufacture directly into the production of gene-modified cells, both adherent cells such as Mesenchymal Stromal/Stem cells and suspension cultures such as CAR T-cells. Virocell Biologics is committed to leveraging its deep experience to rapidly design and select a manufacturing strategy best suited to the client's objectives. The company was founded by Farzin Farzaneh, John W. Hadden. John W. Hadden has been the CEO since incorporation. | Biotechnology | Director/Board Member | |
Apax Partners, Inc.
 Apax Partners, Inc. Investment ManagersFinance Founded in 1976, Apax Partners, Inc. is a venture capital/private equity firm located in New York City. The firm is a subsidiary of London-based Apax Partners LLP | Investment Managers | Corporate Officer/Principal | |
| Cytovia Holdings, Inc. | Director/Board Member | ||
Paul Capital Partners LP
 Paul Capital Partners LP Investment ManagersFinance Founded in 1991 by Philip Paul, Paul Capital Partners LP is a private equity firm located in San Francisco with additional offices in New York City, Hong Kong, London, Paris and São Paulo. | Investment Managers | Private Equity Investor | |
Healthcare Royalty Management LLC
 Healthcare Royalty Management LLC Investment ManagersFinance Healthcare Royalty Management LLC (Healthcare Royalty) is a private equity subsidiary of Cowen, Inc. founded in 2007 by Gregory Brown. The firm is headquartered in Stamford, Connecticut. | Investment Managers | Founder | |
Suneva Medical, Inc.
 Suneva Medical, Inc. Electronic Equipment/InstrumentsElectronic Technology Suneva Medical, Inc. develops, manufactures and commercializes novel, differentiated aesthetic products for the dermatology, plastic, and cosmetic surgery markets. It offers ArteFill, ReFissa, Bellafill, and ReGenica Skincare products. The company is headquartered in San Diego, CA. | Electronic Equipment/Instruments | Chairman | |
| CHROMOCELL THERAPEUTICS CORPORATION | Pharmaceuticals: Major | Chairman | |
| QUALIGEN THERAPEUTICS, INC. | Pharmaceuticals: Other | Director/Board Member | |
| Columbia Business School | College/University | Masters Business Admin |
Statistics
International
| United States | 44 |
| United Kingdom | 5 |
| Canada | 4 |
Sectoral
| Health Technology | 29 |
| Consumer Services | 8 |
| Finance | 8 |
| Commercial Services | 3 |
| Health Services | 2 |
Operational
| Director/Board Member | 97 |
| Independent Dir/Board Member | 38 |
| Corporate Officer/Principal | 32 |
| Chairman | 17 |
| Undergraduate Degree | 16 |
Most connected contacts
| Insiders | |
|---|---|
| Todd Davis | 23 |
| John Kozarich | 21 |
| John LaMattina | 20 |
| Jason Aryeh | 18 |
| John Higgins | 14 |
| Matthew Foehr | 13 |
| Charles Berkman | 12 |
| Sarah Boyce | 11 |
| Matthew Korenberg | 10 |
| Stephen Sabba | 9 |
| Karen Reeves | 8 |
| Richard B. Baxter | 7 |
| Martine Zimmermann | 7 |
| Nancy Gray | 6 |
| Jason Haas | 4 |
- Stock Market
- Insiders
- Andrew Reardon
- Company connections
